HBV VIS Detail Information

> This page shows VIS [1001201] detail information, including site information (chromosome, GRCh38 location, disease, sample, etc) and literature information.


Site Information
DVID 1001201
VISID TVIS10016292
Chromosome chr2
GRCh38 Location 203240158, 203240265
Disease Hepatocellular carcinoma  
Sample Nontumor
Virus Reference Genome NC_003977
Target Gene CYP20A1     
Literature Information
PubMed PMID 22267523
Published year 2012
Journal Genome research
Title The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.
Author Jiang Z,Jhunjhunwala S,Liu J,Haverty PM,Kennemer MI,Guan Y,Lee W,Carnevali P,Stinson J,Johnson S,Diao J,Yeung S,Jubb A,Ye W,Wu TD,Kapadia SB,de Sauvage FJ,Gentleman RC,Stern HM,Seshagiri S,Pant KP,Modrusan Z,Ballinger DG,Zhang Z
Evidence HBV integration into the host genome has been reported, but its scale, impact and contribution to HCC development is not clear. Here, we sequenced the tumor and nontumor genomes (>80x coverage) and transcriptomes of four HCC patients and identified 255 HBV integration sites. Increased sequencing to 240x coverage revealed a proportionally higher number of integration sites. Clonal expansion of HBV-integrated hepatocytes was found specifically in tumor samples. We observe a diverse collection of genomic perturbations near viral integration sites, including direct gene disruption, viral promoter-driven human transcription, viral-human transcript fusion, and DNA copy number alteration. Thus, we report the most comprehensive characterization of HBV integration in hepatocellular carcinoma patients. Such widespread random viral integration will likely increase carcinogenic opportunities in HBV-infected individuals.

Contents
Description
  • Site Information
Detail information of site [1001201]
  • Literature Information
The details of literature that this site is associated with.